Experiences with
Ibrutinib2,003 public posts
Want to take advantage of all our features? Just log in!
or
Understanding mechanisms of resistance to Pirtobrutinib in Chronic Lymphocytic Leukaemia
Covalent Bruton Tyrosine Kinase inhibitors (BTKi) like ibrutinib, acalabrutinib and zanubrutinib have completely changed the treatment landscape for CLL.
CoPay Assistance from LLS (Leukemia & Lymphoma Society) USA
-
In 2015 ONCO-360 arranged my Ibrutinib copay with PAN (Patient Assistance Network). And since 2016, Genentech provided my Venetoclax at no cost when my previous Part D insurance would not cover Venclexta "Off Label"
-
So if you are facing a copay, ask for help actively and don't be shy.
10 Years With CLL: Two Trials & Lifesaving CAR T-Cell Therapy
And that's why CAR T for me, I've probably gone much earlier into CAR T than I was comfortable with, because I was very well on ibrutinib. By six months on ibrutinib, my disease was under control, it was stable.
BTK inhibitor challenges by Dr. Nicole Lamanna
.
-
Nicole Lamanna, MD: With the advent of the BTK [Bruton tyrosine kinase] inhibitors and the fact that we’ve had many individuals on ibrutinib and now even acalabrutinib for many years, there’s no doubt that we’re starting to see some patients who develop resistant mutations to the covalent BTK inhibitors